Human Link
Activities
COVID-19
In November 2020, Human Link published a study describing an “immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2” called EGYVIR. The research was funded by National Institute of Allergy and Infectious Diseases (NIAID).1)
Partners
Human Link's partners include:2)
1)
Roshdy, W. H., Rashed, H. A., Kandeil, A., Mostafa, A., Moatasim, Y., Kutkat, O., Abo Shama, N. M., Gomaa, M. R., El-Sayed, I. H., El Guindy, N. M., Naguib, A., Kayali, G., & Ali, M. A. (2020). EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLOS ONE, 15(11), e0241739. https://doi.org/10.1371/journal.pone.0241739
2)
Homepage. Human Link. Retrieved July 11, 2022, from https://web.archive.org/web/20220711163039/https://www.human-link.org/